Register Login
Register to leave comments
  • News bot June 17, 2026, 12:01 p.m.

    📋 MIRA PHARMACEUTICALS, INC. (MIRA) - Clinical Trial Update

    Filing Date: 2026-06-17

    Accepted: 2026-06-17 08:00:39

    Event Type: Clinical Trial Update

    Event Details:

    MIRA PHARMACEUTICALS, INC. (MIRA) Announces Clinical Trial Update MIRA PHARMACEUTICALS, INC. (MIRA) provided an update on its clinical development programs. Clinical Development Highlights:
    • Diseases/Conditions: neurologic
    • Clinical Stage: clinical trial, Clinical Trial
    • Collaboration: Chemotherapy-Induced Peripheral Neuropathy Randomized

    🔬 Clinical Development Pipeline (MIRA PHARMACEUTICALS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Saline placebo DRUG Phase PHASE1 Hepatitis C ClinicalTrials.gov
    omega-3-carboxylic acids, 4g DRUG Phase PHASE3 Hypertriglyceridemia ClinicalTrials.gov
    omega-3-carboxylic acids, 2g DRUG Phase PHASE3 Hypertriglyceridemia ClinicalTrials.gov
    Olive oil, 4g DRUG Phase PHASE3 Hypertriglyceridemia ClinicalTrials.gov
    ferumoxytol or oral iron DRUG Phase PHASE3 Anemia ClinicalTrials.gov
    MRI 3T scanner DEVICE Phase PHASE1 Esophageal Cancer ClinicalTrials.gov
    Ferumoxytol DRUG Phase PHASE1 Esophageal Cancer ClinicalTrials.gov
    IMO-8400 DRUG Phase PHASE1 Diffuse Large B Cell Lymphoma ClinicalTrials.gov
    IMO-2055 DRUG Phase PHASE2 Renal Cell Carcinoma ClinicalTrials.gov
    Saline DRUG Phase PHASE1 Hepatitis C, Treatment Naïve, Genotype 1 Patients ClinicalTrials.gov
    IMO-2125 DRUG Phase PHASE1 Hepatitis C, Treatment Naïve, Genotype 1 Patients ClinicalTrials.gov
    Printed Handout OTHER Approved Premature Birth ClinicalTrials.gov
    Multimedia Information OTHER Approved Premature Birth ClinicalTrials.gov
    Intravenous normal saline OTHER Approved IDA in the Post-bariatric Surgical Patient ClinicalTrials.gov
    Oral vitamin C OTHER Approved IDA in the Post-bariatric Surgical Patient ClinicalTrials.gov
    Ferrous sulfate DRUG Approved IDA in the Post-bariatric Surgical Patient ClinicalTrials.gov
    Placebo DRUG Phase PHASE2 Dermatomyositis ClinicalTrials.gov
    IMO-8400 Dose Group 2 DRUG Phase PHASE2 Dermatomyositis ClinicalTrials.gov
    IMO-8400 Dose Group 1 DRUG Phase PHASE2 Dermatomyositis ClinicalTrials.gov
    Prasterone (DHEA) DRUG Phase PHASE3 Vaginal Atrophy in Breast Cancer Patients ClinicalTrials.gov
    Prasterone 6.5 mg (0.50%) Vaginal Insert DRUG Phase PHASE3 Hypoactive Sexual Desire Disorder (HSDD) ClinicalTrials.gov
    Placebo Vaginal Insert DRUG Phase PHASE3 Hypoactive Sexual Desire Disorder (HSDD) ClinicalTrials.gov
    Feraheme DRUG Phase PHASE1 Anemia ClinicalTrials.gov
    EPO DRUG Phase PHASE1 Anemia ClinicalTrials.gov
    Saline (0.9% sodium chloride) DRUG Phase PHASE2 Malignant Melanoma ClinicalTrials.gov
    Tilsotolimod DRUG Phase PHASE2 Malignant Melanoma ClinicalTrials.gov
    Aspirin 81mg DRUG Phase PHASE4 Pre-Eclampsia ClinicalTrials.gov
    Prasterone DRUG Phase PHASE3 Recurrent Urinary Tract Infection ClinicalTrials.gov
    17P DRUG Phase PHASE3 Pre-term Birth ClinicalTrials.gov
    Magnetic Resonance Imaging PROCEDURE Phase PHASE2 Brain Neoplasm ClinicalTrials.gov
    Fluconazole 150mg capsule DRUG Phase PHASE3 Recurrent Vulvovaginal Candidiasis ClinicalTrials.gov
    Oteseconazole (VT-1161) 150mg capsule DRUG Phase PHASE3 Recurrent Vulvovaginal Candidiasis ClinicalTrials.gov
    Zofran DRUG Phase PHASE1 Nausea ClinicalTrials.gov
    Bremelanotide DRUG Phase PHASE1 Nausea ClinicalTrials.gov
    AMAG-423 (digoxin immune fab) BIOLOGICAL Phase PHASE2 Severe Preeclampsia ClinicalTrials.gov
    Oral Iron DRUG Phase PHASE3 Iron Deficiency Anemia ClinicalTrials.gov
    moxifloxacin DRUG Phase PHASE1 Anemia ClinicalTrials.gov
    IMO-8400 Regimen 4 DRUG Phase PHASE2 Plaque Psoriasis ClinicalTrials.gov
    IMO-8400 Regimen 3 DRUG Phase PHASE2 Plaque Psoriasis ClinicalTrials.gov
    IMO-8400 Regimen 2 DRUG Phase PHASE2 Plaque Psoriasis ClinicalTrials.gov
    IMO-8400 Regimen 1 DRUG Phase PHASE2 Plaque Psoriasis ClinicalTrials.gov
    Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) DRUG Phase PHASE1 Comparing Bioavailability When Makena® is Administered in Healthy Post-menopausal Women ClinicalTrials.gov
    ASQ-3, Bayley III, Neurologic exam DRUG Preclinical Children Whose Mothers Received 17P and Those Who Received Vehicle in the 17P Efficacy Trial ClinicalTrials.gov
    Vehicle DRUG Phase PHASE3 Preterm Birth ClinicalTrials.gov
    Hydroxyprogesterone Caproate Injection (HPC), 250mg/mL DRUG Phase PHASE3 Preterm Birth ClinicalTrials.gov
    Ipilimumab DRUG Phase PHASE2 Metastatic Melanoma ClinicalTrials.gov
    ABBV-181 DRUG Phase PHASE1 Advanced Solid Tumors Cancer ClinicalTrials.gov
    Nab-paclitaxel DRUG Phase PHASE1 Advanced Solid Tumors Cancer ClinicalTrials.gov
    ABBV-368 DRUG Phase PHASE1 Advanced Solid Tumors Cancer ClinicalTrials.gov
    FCM DRUG Phase PHASE3 Iron Deficiency Anemia ClinicalTrials.gov
    Iron Sucrose DRUG Phase PHASE2 Iron Deficiency ClinicalTrials.gov
    17-Hydroxyprogesterone Caproate 275 mg SC Dose DRUG Preclinical Preterm Birth ClinicalTrials.gov
    17-Hydroxyprogesterone Caproate 250 mg IM Dose DRUG Preclinical Preterm Birth ClinicalTrials.gov
    Ferumoxytol intravenous DRUG Phase PHASE2 Restless Legs Syndrome ClinicalTrials.gov
    Point-of-Care Coagulometer (investigational device) DEVICE Phase PHASE2 Healthy ClinicalTrials.gov
    Ciraparantag DRUG Phase PHASE2 Healthy ClinicalTrials.gov
    IMB-1018972 DRUG Phase PHASE2 Type 2 Diabetes ClinicalTrials.gov
    Vitamin C DRUG Phase PHASE3 Iron Deficiency Anemia ClinicalTrials.gov
    Ferrous sulfate tablets DRUG Phase PHASE3 Iron Deficiency Anemia ClinicalTrials.gov
    Oteseconazole (VT-1161) DRUG Phase PHASE3 Recurrent Vulvovaginal Candidiasis ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: MIRA PHARMACEUTICALS, INC.
    • Ticker Symbol: MIRA

Search

News categories